Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Guided biofilm therapy's effect on gum tissue biomarkers in periodontitis

Official title: Impact of Guided Biofilm Therapy on Gingival Crevicular Fluid Epithelial and Mesenchymal Biomarkers in Periodontitis Patients: A Randomized Controlled Clinical Trial

Run by University of Baghdad · NCT07286916 · Data updated 2026-11-12

This trial will test whether guided biofilm therapy changes gingival crevicular fluid biomarkers in adults with generalized unstable periodontitis.

More Periodontitis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment18 (estimated)
SponsorUniversity of Baghdad
Academic / other
Locations1 site (Baghdad)
StatusRecruiting
StartedJanuary 4, 2026
Main results expectedJune 2026
Study endsJune 2026
Registry record updatedFebruary 27, 2026
Trial IDNCT07286916 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with generalized unstable periodontitis (bilateral symmetric probing depths ≥4 mm and positive bleeding on probing) who are not on antibiotics or regular NSAIDs, not pregnant or breastfeeding, and able to undergo GCF sampling are the ideal candidates.

Probably not a fit

People without periodontitis, those currently taking antibiotics or regular NSAIDs, pregnant or breastfeeding women, patients with heavy calculus that prevents sampling, those with pulmonary disease, or anyone with an erythritol allergy are unlikely to benefit or will be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

All participants will receive the same toothpaste, toothbrush, interdental aids, and brushing instructions, and baseline full-mouth periodontal charting and radiographs will be obtained. Gingival crevicular fluid (GCF) samples will be collected at baseline and one hour later from sites allocated to either guided biofilm therapy (GBT) or control procedures. Control sites receive supragingival ultrasonic debridement initially and root surface debridement (RSD) after one week, while test sites receive the GBT protocol as the alternative non-surgical intervention. Clinical outcomes and epithelial–mesenchymal biomarkers in GCF will be compared between groups to see if GBT produces different biochemical and clinical changes than conventional care.

Why it matters

Potential benefit: If GBT reduces biomarkers linked to tissue breakdown it could enable less invasive or more targeted non-surgical periodontal care and improve gum health.

How similar studies have gone: Previous studies have shown GBT and erythritol air-polishing can reduce plaque and bleeding, but its specific effects on epithelial–mesenchymal biomarkers in GCF are not well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adult subjects (\>18 years).
2. Subjects are not currently under active periodontal therapy or joining other trial in the last 3 months.
3. Patients must be diagnosed with generalized unstable periodontitis with bilateral, symmetrical distribution of PPD ≥ 4mm and positive BOP.

   \-

Exclusion Criteria:

1. Patients not diagnosed with periodontitis.
2. Patients consuming antibiotics.
3. Regular users of nonsteroidal anti-inflammatory drugs (NSAIDs).
4. Patients receiving periodontal treatment 3-months prior to the study.
5. Pregnant or mothers in a breastfeeding period.
6. Third molars and teeth with furcation involvement.
7. Patients taking antioxidant supplements.
8. Patients with heavy calculus that would prevent PerioPaper strips entrance to the periodontal pocket.
9. Patient with pulmonary diseases and with a history of allergy to erythritol.
10. Patients not willing to participate. -

Where it's running

  • College of Dentistry, University of Baghdad
    Baghdad, Iraq
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.